These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1375518)
21. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259 [TBL] [Abstract][Full Text] [Related]
22. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. Carabasi MH; DiSanto JP; Yang SY; Dupont B Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547 [TBL] [Abstract][Full Text] [Related]
23. The molecular basis for the synergism between the CD3/alpha beta T cell receptor and the CD2 antigen-derived signals in promoting T-cell proliferation. Sehajpal PK; Li B; Zanker B; Murthi VK; Subramaniam A; Sharma VK; Estin D; Skolnik EY; Wieder KJ; Walz G Transplantation; 1991 Feb; 51(2):468-74. PubMed ID: 1671615 [TBL] [Abstract][Full Text] [Related]
24. Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation. Anderson P; Blue ML; Morimoto C; Schlossman SF Cell Immunol; 1988 Sep; 115(2):246-56. PubMed ID: 2900689 [TBL] [Abstract][Full Text] [Related]
25. Human thymocytes become lineage committed at an early postselection CD69+ stage, before the onset of functional maturation. Vanhecke D; Verhasselt B; De Smedt M; Leclercq G; Plum J; Vandekerckhove B J Immunol; 1997 Dec; 159(12):5973-83. PubMed ID: 9550395 [TBL] [Abstract][Full Text] [Related]
26. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. Giese T; Allison JP; Davidson WF J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618 [TBL] [Abstract][Full Text] [Related]
27. In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis. Poggi A; Biassoni R; Pella N; Paolieri F; Bellomo R; Bertolini A; Moretta L; Mingari MC J Exp Med; 1990 Nov; 172(5):1409-18. PubMed ID: 2146363 [TBL] [Abstract][Full Text] [Related]
28. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes. Koulova L; Yang SY; Dupont B J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875 [TBL] [Abstract][Full Text] [Related]
29. Signalling in human tumour infiltrating lymphocytes: the CD28 molecule is functional and is physically associated with the CD45R0 molecule. Zocchi MR; Poggi A; Crosti F; Tongiani S; Rugarli C Eur J Cancer; 1992; 28A(4-5):749-54. PubMed ID: 1355979 [TBL] [Abstract][Full Text] [Related]
30. Accelerated proliferation and interleukin-2 production of thymocytes by stimulation of soluble anti-CD3 monoclonal antibody in transgenic mice carrying a rabbit protein kinase C alpha. Iwamoto T; Hagiwara M; Hidaka H; Isomura T; Kioussis D; Nakashima I J Biol Chem; 1992 Sep; 267(26):18644-8. PubMed ID: 1382058 [TBL] [Abstract][Full Text] [Related]
31. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation. Pierrès A; Lopez M; Cerdan C; Nunes J; Olive D; Mawas C Eur J Immunol; 1988 May; 18(5):685-90. PubMed ID: 2454190 [TBL] [Abstract][Full Text] [Related]
32. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293 [TBL] [Abstract][Full Text] [Related]
33. Expression of T cell receptor-alpha and -beta subunits in human thymocytes. An immunocytologic study. Maggiano N; Larocca LM; Piantelli M; Acuto O; Musiani P J Immunol; 1987 Sep; 139(5):1438-45. PubMed ID: 2957426 [TBL] [Abstract][Full Text] [Related]
34. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475 [TBL] [Abstract][Full Text] [Related]
35. Requirements for in vitro growth of human thymocytes. Park SH; Bae YM; Park WS; Kim TJ; Chung DH; Song HG; Cho BJ; Kim CW; Lee SK J Korean Med Sci; 1991 Sep; 6(3):224-33. PubMed ID: 1723278 [TBL] [Abstract][Full Text] [Related]
36. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2. Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455 [TBL] [Abstract][Full Text] [Related]
37. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations. Toribio ML; De la Hera A; Marcos MA; Márquez C; Martínez C Eur J Immunol; 1989 Jan; 19(1):9-15. PubMed ID: 2522051 [TBL] [Abstract][Full Text] [Related]
38. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells. Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456 [TBL] [Abstract][Full Text] [Related]
39. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808 [TBL] [Abstract][Full Text] [Related]
40. Comparison of signals delivered through CD3 and CD2 for T-cell activation: the role of calcium influx and interleukin 1. Wakasugi H; Mahé Y; Huet S; Boumsell L; Bernard A; Tursz T Hum Immunol; 1988 Nov; 23(3):163-78. PubMed ID: 3147981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]